Last week, a total of four fighters from the Bellator 127 event in Temecula, California were revealed to have failed their post-fight drug testing: Robert Emerson, Fernando Gonzales, Keith Berry, and Nick Moghaddam.

That number represented a staggering amount: almost one in five athletes on the card. Our own Jim Genia offered his take on the crime.

Yesterday, California State Athletic Commission Executive Director Andy Foster released the punishments.

According to our friends at MMA Weekly:

(Keith) Berry and (Nick) Moghaddam both tested positive for marijuana and an elevated testosterone-to-epitestosterone ratio exceeding California’s limit of 4-to-1. Berry’s victory over Joe Pacheco was changed to a no contest. He was also suspended for 300 days and fined $2,500 (25-percent of his fight purse). Modhaddam was also suspended 300 days, but his fine was $1,000 or 50-percent of his fight purse.

(Rob) Emerson tested positive for Modafinil, a substance that improves cognitive functioning, wakefulness, and energy, according to the British Journal of Sports Medicine. He received a 270-day suspension and $2,500 fine, which amounted to 35.7-percent of his fight purse.

(Fernando) Gonzalez tested positive for marijuana and was suspended 30 days and fined $315 (2.65-percent of his purse).

Bellator President Scott Coker released a statement last Friday expressing his support for the CSAC’s efforts.

“I want to make very clear that under new management, Bellator will simply not stand for performance enhancing drugs inside our cage,” Coker said. “We fully support the California State Athletic Commission in their process, and standby any disciplinary action handed out by Commissioner Andy Foster and the CSAC. Fans, media and our athletes need to have a clear understanding that drug use will simply not be tolerated by Bellator.”